Castle Biosciences Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Derek Maetzold (60 yo)

15.08yrs

Tenure

US$6,521,857

Compensation

Mr. Derek J. Maetzold founded Castle Biosciences Incorporated in September 2007 and serves as its President, Chief Executive Officer and Director since September 2007. He serves as the Director at AltheaDx...


CEO Compensation Analysis

Derek Maetzold's Compensation vs Castle Biosciences Earnings
How has Derek Maetzold's remuneration changed compared to Castle Biosciences's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-US$44m

Mar 31 2022n/an/a

-US$52m

Dec 31 2021US$7mUS$625k

-US$31m

Sep 30 2021n/an/a

-US$30m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021n/an/a

-US$15m

Dec 31 2020US$5mUS$550k

-US$10m

Sep 30 2020n/an/a

-US$3m

Jun 30 2020n/an/a

US$7m

Mar 31 2020n/an/a

US$6m

Dec 31 2019US$4mUS$770k

US$3m

Sep 30 2019n/an/a

US$4m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$8m

Dec 31 2018US$791kUS$410k

-US$10m

Compensation vs Market: Derek's total compensation ($USD6.52M) is above average for companies of similar size in the US market ($USD3.98M).

Compensation vs Earnings: Derek's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: CSTL's management team is considered experienced (2.3 years average tenure).


Board Members

Experienced Board: CSTL's board of directors are considered experienced (3.2 years average tenure).